In another study, doxorubicin diffusion was impaired due to increased collagen accumulation in the tumor microenvironment due to decreased susceptibility to proteolytic enzymes caused by a serine protease inhibitor Maspin. The gene discussed is SERPINB5; the disease is neoplasm.